Search & Filter

California Attorney General Rob Bonta is suing Heartbeat International and RealOptions, a Bay Area pregnancy clinic network, alleging they mislead women about the safety and effectiveness of Abortion Pill Reversal (APR). A former RealOptions patient from Oakland testified in court that APR saved her pregnancy and praised the clinic's compassionate care throughout her pregnancy journey.

Four states—Nevada, Virginia, Idaho, and Missouri—are key battlegrounds for the pro-life movement this fall, with mixed prospects for restricting abortion amid ongoing ballot measures and campaigns. In California, where reproductive autonomy is constitutionally protected, pro-life advocates may focus on improving support systems for pregnant women to reduce abortion rates, as suggested by the new MOM Score assessing state policies that make motherhood more achievable.

Donna Hecke, Chief Marketing Officer for RealOptions Obria Medical Clinics in the San Francisco Bay Area, testified in the first U.S. trial involving Abortion Pill Reversal (APR), defending the organization's marketing practices against allegations by California Attorney General Rob Bonta.

All public California universities are required by law to provide abortion pills at their student health centers, but only three campuses advertise ultrasounds and none offer comprehensive prenatal care on-site. In 2023, California became the first state to mandate abortion pill availability at public universities, and a new law signed in September requires community colleges to offer abortions on campus as well.

White explains the remaining briefing, closing-argument, and decision stages after testimony ended in California's case against Heartbeat International and RealOptions. She argues that the outcome could affect pregnancy centers' ability to discuss abortion-pill reversal nationwide and asks supporters to remain engaged and prayerful.

Wallenmeyer outlines California's advertising lawsuit against Heartbeat International and RealOptions and explains the organizations' free-speech defense. She challenges the state's interpretation of abortion-pill-reversal research and trial testimony, arguing that women should retain access to information about continuing a pregnancy.